| Patrick J. Beyer | President and Chief Executive Officer | FY2025 | |
| Todd W. Garner – | Executive Vice President, Finance and Chief Financial Officer | FY2022 | |
| Hollie Foust | Executive Vice President, General Counsel and Corporate Secretary | FY2025 | |
| Brent Lalomia | Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations | FY2025 | |
| Peter K. Shagory | Executive Vice President, Strategy and Corporate Development | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.